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ABSTRACT
Objective: The aim of this study was to observe the role of genetic variation T45G and G276T of adiponectin gene in pathomechanism of fatty liver 
on obese subjects.
Methods: An observational study with case–control design was conducted on 94 obese male subjects (50 subjects are obese male with fatty liver and 
44 subjects are obese male without fatty liver). The research is taken place in Prodia Clinical Laboratory Makassar to determine genetic variation single 
nucleotide polymorphism (SNP) T45G (Genotype TT, thyroglobulin [TG], and GG) and SNP G276T (Genotype GG, GT, and TT) of adiponectin gene, technique 
of polymerase chain reaction-restriction fragment length polymorphism was used. The level of adiponectin, soluble tumor necrosis factor-α receptor 2 
(sTNF-αR2), and insulin serum were measured by enzyme-linked immunosorbent assay method, meanwhile, fatty liver was detected by ultrasonography.
Results: The result of the study showed genetic variation, T45G of adiponectin gene was genotype TT 62.8 %, genotype TG 30.9%, and genotype GG 
6.3%; meanwhile, genetic variation G276T of adiponectin gene was genotype GG 43.6%, genotype GT 38.3 %, and genotype TT 18.1 %. There was no 
significant correlation of genetic variation T45G as well as G276T of adiponectin gene, to the level of adiponectin serum (>0.05). Insulin resistance was 
more frequent on genotype TT genetic variation T45G of adiponectin gene as compare to that on TG+GG (p=0.069). Genotype TT on genetic variation 
T45G of adiponectin gene was significant correlated with fatty liver (p=0.010). Genotype TG+TT on genetic variation G276T of adiponectin gene was 
more likely to have insulin resistance and fatty liver than that of genotype GG. Allele T carrier on genetic variation T45G and G276T of adiponectin 
gene had a higher chance to have insulin resistance and fatty liver as compare to that of allele G carrier. The odds ratio of having fatty liver insulin 
resistance is 5.3, genotype TT on genetic variation T45G of adiponectin gene is 3.8, low level of adiponectin is 3.4, and high level of sTNF-αR2 is 3.3.
Conclusion: Genotype TT on genetic variation T45G of adiponectin gene has a role in fatty liver on obese subjects. Genotype TG+TT on genetic 
variation G276T of adiponectin gene was more high frequent to have fatty liver compare to that on genotype GG. Allele T carrier on genetic variation 
T45G of adiponectin gene had higher frequency on the occurrence of insulin resistance than that on allele G carrier. Insulin resistance has the highest 
influence as compare to genotype TT on genetic variation T45G of adiponectin gene, low level of adiponectin serum, high level of sTNF-αR2 serum in 
the pathomechanism of fatty liver in obese subjects.
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INTRODUCTION
Fatty liver is a condition characterized by liver steatosis, an excessive 
buildup of triglycerides and other fats in liver cells caused by an imbalance 
between the production and release of triglycerides by the liver [1,2].
Insulin resistance is a key component in obesity and is known as 
a risk factor for the occurrence of non-alcoholic fatty liver disease 
(NAFLD) [3,4].
Adiponectin and leptin each play a role in increasing the oxidation rate 
of fatty acids and reducing fat in muscle, which is the key for improving 
insulin’s effect [5].
Molecularly, adiponectin may increase insulin sensitivity by enhancing 
the effects of insulin suppression on gluconeogenesis and increasing 
the oxidation of fatty acids in liver cells and muscle cells through the 
mechanism of adenosine monophosphate kinase and peroxisome 
proliferator-activated receptor [6,7].
The concentration of adiponectin in plasma was found to be lower in obese 
subjects compared to non-obese subjects. The mechanisms underlying 
the decrease in plasma adiponectin concentrations are unclear, one of 
which is the inhibition of synthesis and secretion by large-scale locally 
produced tumor necrosis factor-α (TNF-α) tumors, beginning with the 
entry of macrophages into the adipose tissue [7,8]. Activation of TNF-α 
can be measured by measuring the soluble TNF-α receptor 2 (sTNF-αR2). 
sTNF-αR2 is associated with an increase in insulin resistance [9].
Decreased levels of adiponectin may also be due to several genetic 
variations that occur in the promoter, exon, intron 2, and rare mutations 
in exon 3 in human genes where the phenotype is obesity, insulin 
resistance and diabetes risk and coronary heart disease [8].
The genetic variation of adiponectin gene that is reported to be 
associated with insulin resistance, obesity, and risk of Type 2 diabetes 
in intron 2 is G276T and on exon 2 is T45G [11,12].
Research conducted by Xita et al. found the presence of polymorphism 
in the T45G position associated with insulin resistance in polycystic 
ovary syndrome [11]. Research conducted by Zacharova et al. found the 
G allele at position 45 as a predictor of changes in impaired glucose 
tolerance to Type 2 diabetes [13]. Suspected genetic variation of 
adiponectin also plays a role in fatty liver of obese men’s subjects.
Lawrence et al. proposed the theory of translating pendulum hypothesis 
(personal communication) that occurs in the condition of impaired 
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glucose tolerance that is the balance of oxidative stress components 
and antioxidants continuously occur in the journey of life [14]. The 
phenomenon of translating pendulum hypothesis is also thought to 
occur in various metabolic disorders [14].
Pathogenesis of fatty liver is a long journey that begins 
one of them is the interaction between adiponectin genetic 
factors and the environment that causes decreased levels of 
adiponectin (phase molecular phenotype) [14]. Decreasing 
adiponectin as an anti-inflammatory marker will cause the anti-
inflammatory - inflammatory balance to be impaired. If the 
position of inflammation is more, then there will be interference 
in insulin resistance (cellular phenotype phase) that potentially 
the happening of the liver (clinical phenotype), but if the body can 
do the compensation so that the inflammation can be rebalanced, 
then the process of fatty liver can change back to normal. Hence, the 
treatment for fatty liver can be done by improving insulin sensitivity 
by treatment and dietary abdominal decrease.
METHODS
An observational study with case–control design was conducted on 94 
obese male subjects (50 subjects are obese male with fatty liver and 44 
subjects are obese male without fatty liver).
This study received the approval of the Ethics Committee of Biomedical 
research on humans of the Faculty of Medicine, Hasanuddin University.
Subject
The population of the study was male who underwent medical checkup 
at Prodia Clinical Laboratory in Makassar. Research subjects are 
research populations that have met the criteria that have been set.
Sampling was collected by consecutive sampling, i.e., every sample 
who had undergone medical checkup during the research period at the 
Prodia Clinic Laboratory Makassar that fulfilled the above inclusion and 
exclusion requirements, was taken as the subject of the study, until a 
large sample was reached.
Inclusion criteria consist of male subjects aged ≥29 years with waist 
circumference of >90 cm, experiencing fatty liver and without fatty 
liver, subject not alcoholic, and subject not consuming angiotensin 
receptor blocker.
Exclusion criteria consisted of individuals high-sensitivity C-reactive 
protein (Hs-CRP) >10 mg/L, subjects with hepatitis B and C disease, 
subjects with sugar content >126 mg/dl, and subjects who were on a 
weight loss diet program with or without medication.
Determination of blood sugar levels
The concentration of fasting blood sugar level was measured from 
serum in units of mg/dl, taken in fasting state 12–14 h, measured with 
COBAS 501, and using enzymatic method of hexokinase. Reagents are 
manufactured by Roche® Mannheim - Germany with catalog number 
04404483190.
Determination of Hs-CRP levels
The Hs-CRP concentration was measured from serum in units of 
µg/ml, with an Immulite 200 device and using chemiluminescence 
immunoassay method. The reagents are manufactured by Diagnostic 
Product Corporation with LKCRP1 catalog number.
Determination of insulin levels
Insulin concentration was measured from serum in units of mU/mL, 
measured by chemiluminescence immunoassay method using DPC No. 
reagent L2KN2 catalog in Immulite 2000 (Siemens) tool.
Insulin sensitivity was assessed by the formula homeostasis model 
assessment of insulin resistance (HOMA-IR)=(fasting sugar X fasting 
insulin level)/22.5.
Determination of adiponectin levels
The concentration of adiponectin was measured from serum in units 
of µg/ml, by means of reader, by enzyme-linked immunosorbent assay 
(ELISA) method. Reagents are manufactured by Daiichi Sekisui with lot 
number 004RKC ED 2006-06.
Determination of sTNF-αR2 levels
The sTNF-αR2 concentration was measured from the serum in units of 
pg/ml, by means of the reader, by ELISA method. Reagents are produced 
by Quanticine from R and D systems with DRT200 catalog numbers.
HbsAg check
HBsAg was examined from serum in units of µg/ml, with Axymm device, 
using microparticle enzyme immunoassay (MEIA) method with Axsym 
HBsAg Ver. 3 packet catalog 3B44-20.
Antihepatitis C virus (HCV) inspection
Total anti-HCV of serum in units of µg/ml was inspected, with Axymm 
device, by MEIA method, Axsym HBsAg Ver. 2 pack reagent, no. catalog 
7A40-22.
Ultrasound examination
The ultrasound examination was performed by radiologist using the 
well-calibrated Medison SA-606 (Product Medison Co. Ltd - Seoul 
Korea) brand.
Examination of genetic variation
The genotyping of genetic variations of single nucleotide polymorphism 
(SNP) T45G and SNP G276T adiponectin gene was performed by 
allele polymerase chain reaction (PCR) amplification method from 
deoxyribonucleic acid (DNA) genome. DNA is extracted from blood 
containing ethylenediaminetriacetic acid. The PCR reaction consisted 
of amplification of 100 ng template DNA up to a 25 µL volume through 
denaturation at 950C for 5 min, followed by 35 cycles (950C for 45 s, 
550C for 45 s, and 720C for 1 min and extension at 720C for 2 min) [5].
The genetic variation of SNP T45G adiponectin gene using the forward 
primer 5’GAAGTAGACTCTGCTGAGATGG 3’ and reverse primer 
5’TATCAGTGTAGGAGGTCTGTGATG 3’ with the cutting enzyme of SmaI 
(NEB) and the cuts were then electrophoretically separated on 2% 
agarose gel.
The genetic variation of the SNP G276T adiponectin gene using 
the forward 5’CAGGAAACCACGACTCAAGG3’ and reverse primer 
5’GTCTAGGCCCTAGTTAATAATGAAGG3’ with the cutting enzyme Stu 
I (Takara) and the cuts were then separated electrophoresis on 2% 
agarose gel.
Statistics
The data obtained were analyzed with SPSS program for Windows 
version 16.0. The analysis results were narrated and clarified in tables 
and graphs. For the statistical test, the significance level used is 5%. 
Statistical test of univariate method, Spearman one-tailed correlation 
analysis, Mann–Whitney U-test, Chi-square cross tabulation test, and 
multiple logistic regression test.
RESULTS
Characteristics of age and biochemical marker of fatty liver and 
non-fatty liver subjects
Characteristic of age and biochemical marker of fatty liver and non-fatty 
liver subjects were in Table 1. There were no significant differences 
of age between fatty liver and non-fatty liver subjects. There were 
statistically significant differences of the level of insulin, sTNF-αR2, 
HOMA-IR, level of adiponectin between fatty liver and non-fatty liver 
subject (p<0.05).
Genetic variation of SNP T45G and G276T adiponectin gene
Genotype and allele frequency of genetic variation SNP T45G and SNP 
G276T of adiponectin gene can be mentioned in Table 2.
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Analysis of HOMA-IR, genotype TT of genetic variation SNP T45G of 
adiponectin gene, level of sTNF-αR2, and level of adiponectin
The correlation of genotype TT of genetic variation SNP T45G 
adiponectin gene, genotype GT+TT of genetic variation SNP G276T of 
adiponectin gene, level of adiponectin, level of sTNF-α R2, and HOMA-
IR with occurrence of fatty liver can be analyzed with binary logistic 
analysis. The result of analysis can be shown in Table 3.
Subject with insulin resistance (HOMA ≥2) has ×5.3 higher risk in fatty liver 
occurrence than non-insulin resistance subject (HOMA <2). Subject with 
genetic variation SNP T45G of adiponectin gene has ×3.8 higher risk in fatty 
liver occurrence than genotype thyroglobulin (TG)+GG subject. Subject 
with the level of adiponectin <3.30 µg/dl has ×3.4 higher risk in fatty liver 
occurrence than subject with the level of adiponectin ≥3.30 µg/dl. Subject 
with the level of sTNF-αR2 ≥21.78 pg/mL has ×3.3 higher risk in fatty liver 
occurrence than subject with the level of sTNF-αR2 ≥21.78 pg/mL.
The pathomechanism of fatty liver can be proposed with resulting 
of correlation analysis of genotype TT of genetic variation SNP T45G 
adiponectin gene, genotype GT+TT of genetic variation SNP G276T of 
adiponectin gene, level of adiponectin, level of sTNF-αR2, and HOMA-IR 
was described in Fig. 1.
DISCUSSION
Decreased levels of adiponectin may be due to genetic or inflammatory 
factors that develop in the body. Genetic variations of SNP T45G and 
SNP G276T adiponectin gene have been studied in association with 
obesity, insulin resistance, and risk of Type 2 diabetes.
The results of our study showed genetic variation of T45G adiponectin 
genes is TT 60%, TG 29% genotype, and GG genotype 5%. The results 
of González-Sánchez research in Spain 2006 obtained genotype TT 
61.1%, TG 31.9%, and GG 8% in men, and TT 62.6%, TG 33.5%, and 
GG 3.9% in women [9]. Mackevics et al. obtained TT 77.88% genotype, 
TG 21.20% genotype, and genotype GG 0.92% [13]. Xita et al. (2005) 
in his 2002 study found TT genotype 48%, TG 40% genotype, and GG 
genotype 11% [12].
Our results, genetic variation of G276T adiponectin genes is GG 41%, 
genotype GT/TG 36%, and TT genotype 17%. The results of González-
Sánchez research in Spain 2006 obtained genotype GG 51.8%, GT 42.5% 
genotype, and genotype TT 5.7% in men, and genotype GG 49.0%, 
genotype GT/TG 44.0%, and TT 7.0% genotype in women [9]. Mackevics 
et al. in his research in Austria in 2006 obtained genotype GG 50.60%, 
genotype TG 39.83%, and genotype TT 9.57% [13]. Xita et al. (2005) 
found genotype GG 53%, GT genotype 39%, and TT genotype 8% [12].
The association of T45G adiponectin genetic variation with adiponectin 
levels was not statistically significant. In the genetic variation of 
T45G adiponectin gene on adiponectin levels, the TT genotype has 
a lower frequency of adiponectin levels than the TG+GG genotype. 
The association of genetic variation of G276T adiponectin gene with 
adiponectin levels was not statistically significant. In the genetic 
variation of G276T adiponectin gene showed GT+GG genotype has 
a lower frequency of adiponectin levels than with GG genotype. This 
study also showed that T allele carriers have a lower frequency of 
adiponectin levels than the G allele carriers. The results of our study 
were similar to those of González-Sánchez 2005, Mackevics et al. 2006 
found no significant difference in adiponectin levels in the genetic 
variation of adiponectin G276T [11,15].
Adiponectin levels that did not differ significantly on this examination 
were likely due to the relatively small number of samples examined, or 
the likelihood of measuring adiponectin instead of the active substance 
in the form of high-molecular-weight (HMW). In obese individuals, 
oligomers adiponectin has different distributions compared with lean 
controls. Low-molecular-weight and HMW are closely related to obese 
with metabolic complications. Increasing the ratio of HMW to total 
adiponectin is closely related to improved insulin sensitivity during 
the treatment of insulin with thiazolidinedione in both humans and in 
mice [16]. Both in vitro and animal studies support the role of HMW 
oligomers as the main active ingredient mediating the various roles of 
adiponectin in liver tissue [13]. Hsieh et al (2015) found that serum 
levels of adiponectin were negatively associated with NAFLD and that 
percentage of body fat, BMI, and serum levels of TG and ALT were 
positively associated with NAFLD [17].
Table 1: Characteristic of age and biochemical marker of fatty 
liver and non-fatty liver
Variable Unit Mean±SD p
Fatty liver Non-fatty 
liver
n=50 n=44
Age Year 42±9 44±11 0.415
Adiponectin µg/ml 3.11±1.12 3.54±1.06 0.050
sTNF-αR2 µg/ml 23.63±5.91 20.57±5.34 0.004
HOMA-IR 2.54±1.97 1.36±0.93 0.000
p*: Mann–Whitney U-test, sTNF-αR2: Soluble tumor necrosis factor-α receptor 
2, HOMA-IR: Homeostasis model assessment of insulin resistance. SD: Standard 
deviation
Table 2: The genotype and allele frequency of genetic variation 

















SNP: Single nucleotide polymorphism, TG: Thyroglobulin
Table 3: The result of binary logistic analysis genotype TT of genetic variation SNP T45G adiponectin gene, genotype GT+TT of genetic 
variation SNP G276T of adiponectin gene, level of adiponectin, level of sTNF-αR2, and HOMA-IR with occurrence of fatty liver
Factors B SE Wald p Exp (B) 95.0% CI for Exp (B)
Genotype TT of SNP T45G 1.337 0.532 6.324 0.012 3.808 1.343 10.797
Genotype GT+GG of SNP G276T 0.118 0.508 0.054 0.817 1.125 0.415 3.046
Adiponectin 1.240 0.525 5.585 0.018 3.456 1.236 9.664
sTNF-αR2 1.202 0.502 5.725 0.017 3.327 1.243 8.907
HOMA 1.674 0.584 8.219 0.004 5.336 1.698 16.763
Constanta (7.305) 1.979 13.628 0.000 0.001
HOMA: Homeostasis model assessment of insulin resistance, sTNF-αR2: Soluble tumor necrosis factor-alpha receptor. SNP: Single nucleotide polymorphism, SE: 
Standard error, CI: Confidence interval
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the Huang et al. (2010) allele with Taiwanese population indicating 
that individuals with T alleles had a risk of elevated blood sugar 
levels [11].
In the genetic variation of T45G adiponectin gene, TT genotype has 
frequency of fatty liver 62.7%, genotype TG+GG 36.7%. While on 
genetic variation G276T, GG genotype has frequency of fatty liver 
48.8%, GT+TT genotype 54.7%. The result showed that genetic 
variation of T45G adiponectin gene of T allele carrier had 53.4% of 
fatty liver frequency compared to G 34.4% allele carrier, whereas 
on genetic variation of G276T adiponectin gene frequency of fatty 
liver incidence in T 54.7% allele carrier while carrier allele G 50.6%. 
When combined these two genetic variations of T45G and G276T 
adiponectin genes, it can be concluded that T allele carriers play a 
role in fatty liver events, whereas G allele carriers play a role in the 
absence of fatty liver.
Musso et al. (2008) in the study using non-alcoholic steatohepatitis 
(NASH) subjects found a higher frequency of steatosis, higher 
necroinflammation and fibrosis degree in TT genotype on T45G genetic 
variation of adiponectin gene compared with TG+GG genotype [14]. 
While on genetic variation of G276T adiponectin gene found GT/
TT genotype has frequency of occurrence of steatosis, existence of 
nekroinflamasi and degree of fibrosis higher than GG genotype [18].
Musso et al. (2008) found a link between adiponectin genetic variation 
and fatty liver incidence was an increase in postprandial adiponectin 
response to fat intake [18]. Musso et al. also found a decrease in mRNA 
expression in adipocytes carrying T allele versus G allele carriers 
causing decreased transcription and stability of mRNAs that may 
indicate the genetic role of NASH events. In this study can be seen 
the level of adiponectin in obese people with fatty liver is lower than 
those without the fatty liver [18]. Yoon, hypoadiponectinemia occurs in 
NAFLD individuals [19].
Kowalska et al. obtained higher levels of sTNF-αR2 in patients with 
Type 2 diabetes mellitus than controls [20]. Dzienis-Straczkowska 
et al. obtained sTNF-αR2 levels in obese subjects with impaired glucose 
tolerance higher than normal obese people with glucose tolerance 
(p<0.05) in both men and women [21]. González-Sánchez et al. (2005) 
suggested a significant positive association between sTNF-αR2 and 
obesity as measured by BMI [11]. Studies conducted by Hui et al. 
showed decreased adiponectin levels, elevated levels of TNF-α, and 
elevated soluble levels of TNF-α receptor 2 occurred in NASH subjects 
compared to controls [10]. Our results show that the value of HOMA-IR 
in liver fatty subjects is higher than that of subjects without fatty liver. 
Our study demonstrates the close association between adiponectin 
with HOMA-IR values and is associated weakly with sTNF-αR2. Yoon 
et al. (2005) found insulin resistance to be the greatest cause of NAFLD, 
using the HOMA-IR method, as a calculation of elevated levels of insulin 
in the circulation [19]. Our results indicate the role of adiponectin 
against insulin resistance which then causes fatty liver, as well as the 
role of adiponectin balance with sTNF-αR2 to the occurrence of fatty 
liver provides a picture of the course of obesity conditions causing fatty 
liver as in Fig. 2.
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suggested a significant positive association between sTNF-αR2 and 
obesity as measured by BMI [11]. Studies conducted by Hui et al. 
showed decreased adiponectin levels, elevated levels of TNF-α, and 
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